Prevention and treatment of influenza infections.
Iacuzio
D
D
Roche Laboratories Inc, Nutley, NJ, USA.
D000998:Antiviral Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D008297:Male; D009975:Orthomyxoviridae / Q000302:isolation & purification*; D011379:Prognosis; D012141:Respiratory Tract Infections / Q000821:virology*; D016896:Treatment Outcome; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D017778:Vaccines, Combined / Q000008:administration & dosage
D000998:Antiviral Agents; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined